# ASPIRIN: Neurodevelopmental Follow-up Trial

> **NCT04888377** · — · COMPLETED · sponsor: **NICHD Global Network for Women's and Children's Health** · enrollment: 666 (actual)

## Conditions studied

- Neurodevelopmental Abnormality

## Interventions

- **DRUG:** Aspirin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04888377
- **Lead sponsor:** NICHD Global Network for Women's and Children's Health
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-01
- **Primary completion:** 2022-06-15
- **Final completion:** 2022-06-15
- **Target enrollment:** 666 (ACTUAL)
- **Last updated:** 2024-10-21

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04888377

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04888377, "ASPIRIN: Neurodevelopmental Follow-up Trial". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04888377. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*